Novel Viral Vectors for Gene Therapy 2023
Viral vectors are gene transfer tools assembled from the backbones of naturally occurring viruses. These replication-incompetent vehicles transfer assigned payloads into eukaryotic cells. Numerous viral vector systems that influence cells or tissues have been used to perform basic and preclinical re...
Tallennettuna:
| Aineistotyyppi: | Online |
|---|---|
| Kieli: | englanti |
| Julkaistu: |
MDPI - Multidisciplinary Digital Publishing Institute
2024
|
| Aiheet: | |
| Linkit: | ONIX_20240514_9783725805303_347 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
| _version_ | 1869521102486634496 |
|---|---|
| collection | Directory of Open Access Books |
| description | Viral vectors are gene transfer tools assembled from the backbones of naturally occurring viruses. These replication-incompetent vehicles transfer assigned payloads into eukaryotic cells. Numerous viral vector systems that influence cells or tissues have been used to perform basic and preclinical research. Some virus-derived vectors found their way into clinical practice. |
| format | Online |
| id | doab-20.500.12854ir-137751 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2024 |
| publishDateRange | 2024 |
| publishDateSort | 2024 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1377512024-05-14T14:20:51Z Novel Viral Vectors for Gene Therapy 2023 Herchenröder, Ottmar Pützer, Brigitte sickle cell disease thalassemia globin gene therapy γ-globin lentiviral vector HbF HPFH enhancers -117 HPFH type CD34+ hematopoietic stem cells viral vector gene therapy cancer chronic disease vaccines preclinical models clinical trials approved drugs brain tumour oncolytic virus receptor therapy AAV8 VLP nES GEMMA DMA cryo-TEM reovirus oncolytic viral therapy Ras pathway chemotherapy stemness pluripotency cytolysis reprogramming innate immune adeno-associated virus lentivirus adenovirus adenovirus vector replication-competent adenovirus limiting dilution animal-origin-free culture media vaccine SARS-CoV-2 spike protein genetically modified organisms (GMOs) viral vectors virucidal activity suspension tests virus inactivation disinfection AAV vector adeno-associated virus (AAV) novel serotype porcine capsid bovine capsid luciferase imaging transduction n/a thema EDItEUR::U Computing and Information Technology::UY Computer science Viral vectors are gene transfer tools assembled from the backbones of naturally occurring viruses. These replication-incompetent vehicles transfer assigned payloads into eukaryotic cells. Numerous viral vector systems that influence cells or tissues have been used to perform basic and preclinical research. Some virus-derived vectors found their way into clinical practice. 2024-05-14T14:20:47Z 2024-05-14T14:20:47Z 2024 book ONIX_20240514_9783725805303_347 9783725805303 9783725805297 https://directory.doabooks.org/handle/20.500.12854/137751 eng application/octet-stream Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/8984 https://mdpi.com/books/pdfview/book/8984 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-7258-0529-7 10.3390/books978-3-7258-0529-7 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783725805303 9783725805297 214 open access |
| spellingShingle | sickle cell disease thalassemia globin gene therapy γ-globin lentiviral vector HbF HPFH enhancers -117 HPFH type CD34+ hematopoietic stem cells viral vector gene therapy cancer chronic disease vaccines preclinical models clinical trials approved drugs brain tumour oncolytic virus receptor therapy AAV8 VLP nES GEMMA DMA cryo-TEM reovirus oncolytic viral therapy Ras pathway chemotherapy stemness pluripotency cytolysis reprogramming innate immune adeno-associated virus lentivirus adenovirus adenovirus vector replication-competent adenovirus limiting dilution animal-origin-free culture media vaccine SARS-CoV-2 spike protein genetically modified organisms (GMOs) viral vectors virucidal activity suspension tests virus inactivation disinfection AAV vector adeno-associated virus (AAV) novel serotype porcine capsid bovine capsid luciferase imaging transduction n/a thema EDItEUR::U Computing and Information Technology::UY Computer science Novel Viral Vectors for Gene Therapy 2023 |
| title | Novel Viral Vectors for Gene Therapy 2023 |
| title_full | Novel Viral Vectors for Gene Therapy 2023 |
| title_fullStr | Novel Viral Vectors for Gene Therapy 2023 |
| title_full_unstemmed | Novel Viral Vectors for Gene Therapy 2023 |
| title_short | Novel Viral Vectors for Gene Therapy 2023 |
| title_sort | novel viral vectors for gene therapy 2023 |
| topic | sickle cell disease thalassemia globin gene therapy γ-globin lentiviral vector HbF HPFH enhancers -117 HPFH type CD34+ hematopoietic stem cells viral vector gene therapy cancer chronic disease vaccines preclinical models clinical trials approved drugs brain tumour oncolytic virus receptor therapy AAV8 VLP nES GEMMA DMA cryo-TEM reovirus oncolytic viral therapy Ras pathway chemotherapy stemness pluripotency cytolysis reprogramming innate immune adeno-associated virus lentivirus adenovirus adenovirus vector replication-competent adenovirus limiting dilution animal-origin-free culture media vaccine SARS-CoV-2 spike protein genetically modified organisms (GMOs) viral vectors virucidal activity suspension tests virus inactivation disinfection AAV vector adeno-associated virus (AAV) novel serotype porcine capsid bovine capsid luciferase imaging transduction n/a thema EDItEUR::U Computing and Information Technology::UY Computer science |
| topic_facet | sickle cell disease thalassemia globin gene therapy γ-globin lentiviral vector HbF HPFH enhancers -117 HPFH type CD34+ hematopoietic stem cells viral vector gene therapy cancer chronic disease vaccines preclinical models clinical trials approved drugs brain tumour oncolytic virus receptor therapy AAV8 VLP nES GEMMA DMA cryo-TEM reovirus oncolytic viral therapy Ras pathway chemotherapy stemness pluripotency cytolysis reprogramming innate immune adeno-associated virus lentivirus adenovirus adenovirus vector replication-competent adenovirus limiting dilution animal-origin-free culture media vaccine SARS-CoV-2 spike protein genetically modified organisms (GMOs) viral vectors virucidal activity suspension tests virus inactivation disinfection AAV vector adeno-associated virus (AAV) novel serotype porcine capsid bovine capsid luciferase imaging transduction n/a thema EDItEUR::U Computing and Information Technology::UY Computer science |
| url | ONIX_20240514_9783725805303_347 |